
An antidiabetic drug can help to treat a rare type of brain and spinal cord cancer

A biotech company has designed an innovative enzyme – a recombinant exebacase to destroy staphylococcus aureus

MSD has published Phase II study data suggesting the candidate is effective to treat exacerbations of relapsing multiple sclerosis

The risks of multi-drug resistant tuberculosis have been significantly exacerbated due to the pandemic

Compared to other opioids, tramadol is associated with a higher risk of adverse outcomes

The biotech company and its candidate VE303 have demonstrated success in treating Clostridioides difficile infections

High efficiency HEPA air filters can remove SARS-CoV-2 particles from the air

Scientists from the Karolinska Institute have compared frequently prescribed medications for multiple sclerosis and have identified the most effective of them

Keytruda has shown improved survival rate in chemotherapy with or without bevacizumab in patients with 3 types of cervical cancer
